This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: The General Hospital Corporation. Active years: 2012-2015.
Company Filing History:
Years Active: 2012-2015
Title: Innovations by Bryan C. Fuchs
Introduction
Bryan C. Fuchs is a notable inventor based in Quincy, MA (US). He has made significant contributions to the field of medical research, particularly in the treatment and diagnosis of liver diseases. With a total of 2 patents, his work focuses on innovative therapeutic and diagnostic methods.
Latest Patents
Fuchs' latest patents include groundbreaking methods for treating liver fibrosis and pre-cirrhosis using epidermal growth factor receptor inhibitors. This invention aims to utilize these inhibitors to reduce fibrosis in subjects. Additionally, he has developed diagnostic methods that leverage epidermal growth factor (EGF) expression and polymorphisms to predict the risk of developing cancer, particularly hepatocellular carcinoma (HCC) in patients with inflammatory liver diseases. These methods involve identifying specific genetic variations and EGF expression levels to assess cancer susceptibility.
Career Highlights
Bryan C. Fuchs is associated with The General Hospital Corporation, where he continues to advance his research and innovations. His work has the potential to significantly impact the treatment and understanding of liver-related diseases.
Collaborations
Fuchs has collaborated with esteemed colleagues, including Kenneth Tanabe and Hiroshi Kawasaki, to further enhance his research efforts and innovations in the medical field.
Conclusion
Bryan C. Fuchs is a prominent inventor whose work in liver disease treatment and diagnosis showcases his commitment to advancing medical science. His innovative patents reflect a dedication to improving patient outcomes and understanding complex health issues.